Could GILZ Be the Answer to Glucocorticoid Toxicity in Lupus?
Glucocorticoids (GC) are used globally to treat autoimmune and inflammatory disorders. Their anti-inflammatory actions are mainly mediated via binding to the glucocorticoid receptor (GR), creating a GC/GR complex, which acts in both the cytoplasm and nucleus to regulate the transcription of a host o...
Main Authors: | Jacqueline K. Flynn, Wendy Dankers, Eric F. Morand |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.01684/full |
Similar Items
-
GILZ Regulates the Expression of Pro-Inflammatory Cytokines and Protects Against End-Organ Damage in a Model of Lupus
by: Champa Nataraja, et al.
Published: (2021-04-01) -
GILZ as a mediator of the anti-inflammatory effects of glucocorticoids
by: Simona eRonchetti, et al.
Published: (2015-11-01) -
Development of novel treatment strategies for inflammatory diseases- Similarities and divergence between glucocorticoids and GILZ
by: Qiang eCheng, et al.
Published: (2014-07-01) -
Rôle de GILZ (Glucocorticoid-induced leucine zipper) dans l’apoptose du polynucléaire neutrophile et la résolution de l’inflammation
by: Espinasse, Marie-Alix
Published: (2014) -
Implicating the Role of GILZ in Glucocorticoid Modulation of T-Cell Activation
by: Lorenza Cannarile, et al.
Published: (2019-08-01)